Alzchem Group AG implements long-term succession planning for Management Board: Supervisory Board appoints Martina Spitzer as Chief Sales Officer effective January 1, 2025

Alzchem Group AG implements long-term succession planning for Management Board: Supervisory Board appoints Martina Spitzer as Chief Sales Officer effective January 1, 2025

Trostberg, December 4, 2024 – Alzchem Group AG, a globally active specialty chemicals company, is setting the course for continuous and sustainably successful development in Management as well. At its meeting today, the Supervisory Board approved the appointment of Martina Spitzer as a new member of the Management Board for a term of three years from January 1, 2025 to December 31, 2027. In her new position as Chief Sales Officer (CSO), she will be responsible for the areas of Health & Nutrition (Creapure®), Fine Chemicals (Chemicals & Applications) and Sustainability (ESG).

Ms. Spitzer’s appointment as CSO represents the next important step in the early succession planning for the Management Board. Ms. Spitzer is now already taking over two important business areas in sales, as Dr. Weichselbaumer will be in charge of the future project of setting up production in the USA.

Markus Zöllner, Chairman of the Supervisory Board of Alzchem Group AG: “Ms. Spitzer can look back on an impressive career within the Alzchem Group. It was therefore the next logical step for us to appoint her to the Management Board as an experienced manager. There, she will not only contribute her extensive expertise in marketing and sales, but also a clear vision for innovation and sustainability. With her, we are also continuing our proven strategy of relying on internal solutions with extensive knowledge of the company and comprehensive industry expertise on the Management Board in order to ensure the success of the Alzchem Group AG in the long term through continuity and stability.”

Ms. Spitzer has been with the Alzchem Group since 1999. In 2020, she was appointed Head of Alzchem’s entire chemical sales division, before she shifted her focus to strategic corporate development and ESG in 2022 after around 15 years in sales. In this role, she was instrumental in the introduction of the sustainability division, the optimization of central business processes and the implementation of forward-looking projects.

About Alzchem

Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem offers answers to various global developments such as climate change, population growth and increasing life expectancy. We deliver solutions through brands and products of the highest quality and through a sustainable vision to help shape global developments.

The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective. 

Alzchem Group AG’s broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw materials. These offerings are the company’s response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments.

The company employs around 1,690 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of EUR 540.6 million and EBITDA of EUR 81.4 million in 2023.